Clinton Group Inc. reduced its position in Humana Inc. (NYSE:HUM) by 0.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,694 shares of the insurance provider’s stock after selling 117 shares during the period. Clinton Group Inc.’s holdings in Humana were worth $5,220,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of HUM. BlackRock Inc. boosted its position in Humana by 2,281.7% in the 1st quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock valued at $2,553,487,000 after buying an additional 11,867,056 shares during the last quarter. FMR LLC boosted its position in Humana by 57.9% in the 1st quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock valued at $1,041,184,000 after buying an additional 1,851,197 shares during the last quarter. Renaissance Technologies LLC boosted its position in Humana by 84.3% in the 1st quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock valued at $554,867,000 after buying an additional 1,231,400 shares during the last quarter. Wellington Management Group LLP boosted its position in Humana by 2,651.1% in the 1st quarter. Wellington Management Group LLP now owns 775,755 shares of the insurance provider’s stock valued at $159,915,000 after buying an additional 747,557 shares during the last quarter. Finally, AQR Capital Management LLC boosted its position in Humana by 413.8% in the 1st quarter. AQR Capital Management LLC now owns 736,019 shares of the insurance provider’s stock valued at $151,723,000 after buying an additional 592,772 shares during the last quarter. 95.12% of the stock is owned by institutional investors.

In other news, insider William Kevin Fleming sold 3,071 shares of Humana stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total transaction of $770,759.58. Following the sale, the insider now directly owns 7,681 shares in the company, valued at approximately $1,927,777.38. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Bruce D. Broussard sold 12,000 shares of Humana stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the sale, the chief executive officer now owns 80,086 shares in the company, valued at $20,172,061.68. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 55,595 shares of company stock worth $14,133,706. 0.80% of the stock is owned by company insiders.

Humana Inc. (HUM) traded up 0.36% during midday trading on Friday, reaching $243.63. 1,541,056 shares of the company traded hands. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $259.76. The firm has a market capitalization of $35.21 billion, a price-to-earnings ratio of 20.04 and a beta of 0.87. The firm’s 50 day moving average price is $250.95 and its 200 day moving average price is $232.23.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The business had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same period in the previous year, the business earned $2.30 EPS. On average, analysts expect that Humana Inc. will post $11.55 earnings per share for the current year.

The firm also recently announced a dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 29th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is currently 13.06%.

A number of equities analysts have weighed in on the stock. UBS AG reissued a “neutral” rating and issued a $237.00 price objective (up from $205.00) on shares of Humana in a research report on Wednesday, June 28th. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a research report on Wednesday, August 23rd. Morgan Stanley upped their price objective on shares of Humana from $269.00 to $276.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. Zacks Investment Research cut shares of Humana from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $223.00 price objective (up from $200.00) on shares of Humana in a research report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. Humana has an average rating of “Buy” and a consensus target price of $246.60.

COPYRIGHT VIOLATION NOTICE: “Clinton Group Inc. Has $5.22 Million Holdings in Humana Inc. (HUM)” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/clinton-group-inc-has-5-22-million-holdings-in-humana-inc-hum/1599115.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.